Alyeska Investment Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-654,322
Closed -$12.1M 381
2018
Q4
$12.1M Sell
654,322
-541,032
-45% -$12.9M 0.18% 151
2018
Q3
$30.7M Buy
+1,195,354
New +$27.4M 0.34% 95
2017
Q4
Sell
-1,870,814
Closed -$26.8M 433
2017
Q3
$26.8M Sell
1,870,814
-370,440
-17% -$5.6M 0.2% 149
2017
Q2
$38.8M Sell
2,241,254
-685,687
-23% -$8.22M 0.32% 112
2017
Q1
$32.3M Buy
2,926,941
+1,416,447
+94% +$19.5M 0.26% 133
2016
Q4
$21.9M Buy
1,510,494
+137,606
+10% +$2.52M 0.18% 190
2016
Q3
$33.7M Sell
1,372,888
-1,466,476
-52% -$38M 0.31% 108
2016
Q2
$57.2M Buy
2,839,364
+639,364
+29% +$18.1M 0.54% 51
2016
Q1
$57.9M Buy
+2,200,000
New +$163M 0.53% 58
2015
Q4
Sell
-3,652
Closed -$651K 383
2015
Q3
$651K Buy
+3,652
New +$852K 0.01% 410
2015
Q1
Sell
-4,619
Closed -$661K 499
2014
Q4
$661K Buy
+4,619
New +$621K 0.01% 425
2014
Q3
Sell
-65,047
Closed -$8.2M 388
2014
Q2
$8.2M Buy
65,047
+3,797
+6% +$484K 0.18% 175
2014
Q1
$8.07M Buy
+61,250
New +$8.37M 0.22% 162

Other funds holding BHC

Alyeska Investment Group's BHC Position: Q1 2019 in Review

Alyeska Investment Group sold out of Bausch Health (BHC) in Q1 2019, closing a stake of 654,322 shares — an estimated $12.1M sold.

Alyeska Investment Group first reported a position in BHC in Q1 2014 and held it in 13 quarters. The position peaked at $57.9M in Q1 2016. 349 funds tracked by Wall St. Rank hold BHC as of Q1 2019.

  • Alyeska Investment Group reported no remaining Bausch Health position as of Q1 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 654,322 Bausch Health shares in Q1 2019, an estimated $12.1M.
  • Alyeska Investment Group first reported a position in Bausch Health in Q1 2014 and held it in 13 quarters.
  • Alyeska Investment Group's Bausch Health position peaked at $57.9M in Q1 2016.
  • 349 funds tracked by Wall St. Rank held Bausch Health as of Q1 2019.

Based on Alyeska Investment Group's 13F filing for Q1 2019, filed 15 May 2019.